Sage Journals: Discover world-class research

Retricted access

Research article

First published 2012-3

Brentuximab Vedotin: A New Age in the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Stephanie S Minich

Annals of Pharmacotherapy

Retricted access

Case report

First published 2021-3

Rapid desensitization to brentuximab vedotin after severe anaphylaxis in the treatment of refractory Hodgkin’s lymphoma

Rosalaura V. Villarreal-Gonzalez, Sandra N. Gonzalez-Diaz, Cindy E. de Lira-Quezada [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-10

A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment

Hacer Berna Afacan Öztürk, Murat Albayrak, Çiğdem Pala Öztürk [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024-6

Brentuximab vedotin therapy followed by autologous peripheral stem cell transplantation as a viable treatment option for an older adult with transformed lymphoma: a case report and literature review

Jiewen Tan, Jinman Zhong, Wanzhen Hu [...]

Journal of International Medical Research

Open access

Review article

First published 2012

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkins Lymphoma: Focus on Brentuximab Vedotin

Michelle Furtado, Simon Rule

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2020

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies

Theodoros P. Vassilakopoulos, John V. Asimakopoulos, Kostas Konstantopoulos [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2023-4

Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series

Alessandro Broccoli, Lisa Argnani, Paolo Elia Coppola [...]

Tumori Journal

Retricted access

Case report

First published 2021-3

Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report

Ahmet K. Gunes, Ilknur Demir, Mustafa Pehlivan

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2019-5

Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma

Vanessa Van-de-Velde, Youwen Zhou

Journal of Cutaneous Medicine and Surgery

Free access

Review article

First published 2017-5

Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab

Nathan D. Gay, Craig Y. Okada, Andy I. Chen [...]

Therapeutic Advances in Hematology

Search results